@article{0fa9d173b1b64825bb96a3dbccaffcb9,
title = "Multimodal Longitudinal Neurophysiological Investigations in Dopa-Responsive Dystonia",
author = "Anne Weissbach and Annika Steinmeier and Pauly, {Martje G.} and Al-Shorafat, {Duha M.} and Gerard Saranza and Lang, {Anthony E.} and Norbert Br{\"u}ggemann and Vera Tadic and Christine Klein and Katja Lohmann and Brown, {Matt J.N.} and Christian Beste and Alexander M{\"u}nchau and Tobias B{\"a}umer",
note = "Funding Information: A.W. reports the following: Else Kr{\"o}ner‐Fresenius grant (EKFS, 2018_A55), German Research Foundation (DFG, WE5919/2–1), and Edmond J. Safra Fellowship in Movement Disorders from The Michael J. Fox Foundation and employment at the University Medical Center Schleswig‐Holstein, Campus L{\"u}beck. A.S. has nothing to report. M.G.P. reports the following: employment at the University Medical Center Schleswig‐Holstein, Campus L{\"u}beck. D.M.A. reports the following: employment at the Jordan University of Science and Technology, Irbid, Jordan and a scholarship from Jordan University of Science and Technology. G.S. reports the following: employment at Toronto Western Hospital, Toronto, Ontario, Canada and fellowship training supported by the Parkinson's Foundation. A.E.L. reports the following: employment at Toronto Western Hospital, Toronto, Ontario, Canada. N.B. reports the following: consultancies with Centogene and Bridgebio; grants from the German Research Foundation (BR4328/2–2, GRK1957), Collaborative Center for X‐linked Dystonia‐Parkinsonism, and Else‐Kr{\"o}ner Fresenius‐Stiftung (HA17_2017); and employment at the University Medical Center Schleswig‐Holstein, Campus L{\"u}beck. V.T. reports the following: employment at University Medical Center Schleswig‐Holstein, Campus L{\"u}beck. C.K. reports the following: consultancies with Centogene, honorarium for speaking from Desitin; grants from the German Research Foundation (SFB936 project C5 and FOR2488), and employment at theUniversity Medical Center Schleswig‐Holstein, Campus L{\"u}beck. K.L. reports the following: grants from the German Research Foundation, Damp Foundation, International Parkinson and Movement Disorder Society, and The Michael J. Fox Foundation (GP2 consortium) and employment at University of L{\"u}beck. M.J.N.B. reports the following: employment at California State University Sacramento, Sacramento, CA. C.B. reports the following: honoraria from Genzyme, Bayer, Novartis, and Teva; a grant from the German Research Foundation (FOR 2698); and employment at the Technical University Dresden, Dresden, Germany. A.M. reports the following: consultancies with Desitin, Merz Pharmaceuticals, and Admedicum; advisory boards of German Tourette Syndrome Association and Alliance of Patients With Chronic Rare Diseases; honoraria from Pharm Allergan, Ipsen, Merz Pharmaceuticals, Actelion, GlaxoSmithKline, Desitin, Teva, and Takeda; grants from Possehl‐Stiftung (L{\"u}beck, Germany), Margot und J{\"u}rgen Wessel Stiftung (L{\"u}beck, Germany), Tourette Syndrome Association (Germany), Interessenverband Tourette Syndrom (Germany), Cure Huntington Disease Initiative (CHDI), and Damp‐Stiftung (Kiel, Germany); academic research support from Deutsche Forschungsgemeinschaft Projects 1692/3–1, 4–1, SFB 936, and FOR 2698 (project numbers 396, 914, 663, 396, 577, 296, 396, 474, 989) and European Reference Network–Rare Neurological Diseases (Project 739510) employment at the University of L{\"u}beck and University Medical Center Schleswig‐Holstein, Campus L{\"u}beck; and royalties for the book (Oxford University Press). T.B. reports the following: advisory boards of Ipsen Pharma, Allergan, and Merz Pharmaceuticals; honoraria from Ipsen Pharma, Allergan, and Merz Pharmaceuticals; Grants, Research Group, DFG FOR 2698; and employment with the University Medical Center Schleswig‐Holstein, Campus L{\"u}beck. Neurogenetics Funding Information: This study was supported by the Else Kr{\"o}ner‐Fresenius Foundation (2018_A55) and the German Research Foundation (WE 5919/2‐1, SFB936 project C5, and FOR2488). Support by the European Reference Network–Rare Neurological Diseases (Project 739510) is also gratefully acknowledged. ",
year = "2021",
month = aug,
doi = "10.1002/mds.28679",
language = "English",
volume = "36",
pages = "1986--1987",
journal = "Movement Disorders",
issn = "0885-3185",
number = "8",
}
